Bactroban Nasal

  • Skin infections (topicals)

Bactroban Nasal Generic Name & Formulations

General Description

Mupirocin (as calcium) 2%; oint.

Pharmacological Class


How Supplied

Oint—22g; Crm—15g, 30g; Nasal (single-use) (1g)—10


Bactroban Nasal Indications


Eradication of nasal colonization of methicillin-resistant S. aureus (MRSA) in adult patients and healthcare workers in certain institutional settings during outbreaks of infections with MRSA (see literature).

Bactroban Nasal Dosage and Administration


Apply approximately 0.25g to inside of each nostril twice daily for 5 days. Spread ointment by repeatedly closing and releasing the nostrils for 1 minute after application.


Not recommended.

Bactroban Nasal Contraindications

Not Applicable

Bactroban Nasal Boxed Warnings

Not Applicable

Bactroban Nasal Warnings/Precautions


Avoid eyes. Nasal use in high-risk patients: see full labeling regarding autoinfection. Discontinue if sensitization or severe local irritation occurs. Prolonged use may result in superinfection. Pregnancy. Nursing mothers.

Bactroban Nasal Pharmacokinetics

See Literature

Bactroban Nasal Interactions


Nasal: avoid other concomitant nasal products.

Bactroban Nasal Adverse Reactions

Adverse Reactions

Topical: burning, stinging, pain, itching. Nasal: headache, rhinitis, respiratory disorder, pharyngitis, taste perversion, burning/stinging, cough, pruritus; severe allergic reactions, C. difficile-associated diarrhea.

Bactroban Nasal Clinical Trials

See Literature

Bactroban Nasal Note

Not Applicable

Bactroban Nasal Patient Counseling

See Literature